Sandbox AQ (Quantum Security & AI Platforms) Dossier

Operating as a leader in enterprise quantitative AI and post-quantum cryptography, Sandbox AQ (Quantum Security & AI Platforms) generates its primary revenue through software subscriptions and usage-based pricing for advanced computing and simulations. By delivering its Large Quantitative Models and simulation capabilities via major cloud platforms, Sandbox AQ (Quantum Security & AI Platforms) targets high-value, multi-million-dollar domains such as post-quantum cryptography remediation, drug discovery, and financial modeling. Serving global enterprises and government agencies, Sandbox AQ (Quantum Security & AI Platforms) secures long-term recurring revenue contracts across the telecommunications, healthcare, technology, and defense sectors, working alongside notable entities like Vodafone Business, SoftBank Corp, Mount Sinai Health System, and the United States Department of Defense.

### Financial Highlights

• Total Funding Raised: $950,000,000

• Latest Valuation: $5,750,000,000

• Quantum Computing Platform Mindshare: 4.9%

• Total Patent Documents: 98

• Granted Patents: 42

• Operational Employee Count: 342

• Employee Retention Rate: 91%

Sandbox AQ... Sign in / Sign up to learn more about SandboxAQ

Continue your research by chatting with our AI financial analyst about SandboxAQ. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• How do Sandbox AQ's strategic partnerships with hyperscalers like Google Cloud and hardware providers like Nvidia accelerate the commercial scalability and margin profile of its Large Quantitative Models within multi-million-dollar enterprise contracts?
• Given its 4.9% mindshare in the quantum computing platform category, what specific competitive advantages does Sandbox AQ leverage through its proprietary physics-aware models to defend its market position against heavily resourced tech giants such as IBM and Microsoft?
• In light of the governance and reputational risks associated with the December FY2025 executive lawsuit alleging inflated financial metrics, how might this litigation impact Sandbox AQ's enterprise sales cycles and its current $5.75 billion valuation?
• As Sandbox AQ targets high-value use cases to justify its premium subscription pricing, how effectively does its innovation pipeline—specifically AQBioSim for drug discovery and MagNav for quantum sensing—diversify Sandbox AQ's revenue base beyond its core cryptographic remediation software?
• Having secured $950 million in total funding, how is Sandbox AQ balancing the substantial capital requirements of its multi-year R&D roadmap for quantum-AI technologies against the imperative to demonstrate near-term commercial ROI to its institutional backers?